Farewell to the Blockbuster? The blockbuster drug era is widely reported to be coming to an end. Last year GEN reported (as did many others): “The blockbuster drug model once reigned supreme. Now it is being succeeded by the precision medicine model. During this transition, the pharmaceutical industry may worry about losing the blockbuster model’s[…]
How to Select the Right Pharmaceutical Sourcing Model
LGM Pharma Tags: APIspharmaceutical sourcingsourcingstrategic sourcingsupply chain Feb 07, 2020
Behind the Scenes with LGM Pharma’s API Sourcing Team
Drug Research & Development API, LGM Pharma Tags: APICMOLGMpharmaprocurementsourcingteam Oct 02, 2019
Running a marathon is just like what we do here at LGM Pharma – and in more ways than one, as it turns out. First, the obvious: Both API sourcing and marathons are a long game. Marathons are 26.2 miles long (or longer) – and drug development & commercialization (and therefore API sourcing) is measured[…]
9 Key Sourcing Challenges for Small Pharma
Drug Research & Development API, LGM Pharma Tags: APIAPIsDMFDrug Developmentlogisticspharmascale-upsourcingsupply chainvirtual pharma Sep 05, 2019
Pharma and biopharmaceutical supply chains continue to grow more complex & global. The process of sourcing active pharmaceutical ingredients (APIs) and intermediates has also become more challenging. In 2018, ISR Reports looked at how experience and capacity impact small molecule API outsourcing. Among the findings, about 25% of respondents indicated their company lacked the capacity[…]
